BioSniper
ZH
Toggle language
Open menu
Phase 2 Readout
~quarter
Phase 2 Readout: chs-114
June 30, 2026
Company
Coherus Oncology, Inc. (CHRS)
Drug
chs-114
Track this catalyst and more
Get real-time alerts, AI-powered analysis, and full catalyst coverage.
Start Free
Full Calendar
CHRS Overview
PDUFA Dates
Phase 3 Readouts
Phase 2 Readout: chs-114 — CHRS Phase 2 Readout | BioSniper